News summary
[Puli Pharmaceutical: The China Securities Regulatory Commission decided to file a case against the company because the company failed to disclose its 2023 annual report within the statutory time limit] Securities Times e Company Newsslotsroomcasino, Puli Pharmaceutical (300630) announced on the evening of May 8slotsroomcasino, the company is suspected of violating information disclosure because it failed to disclose its 2023 annual report within the statutory time limit.slotsroomcasino.slotsroomcasino..
Newsletter text
[Puli Pharmaceutical: The China Securities Regulatory Commission decided to file a case against the company because the company failed to disclose its 2023 annual report within the statutory time limit] Securities Times e Company News, Puli Pharmaceutical (300630) announced on the evening of May 8 that the company failed to disclose the 2023 annual report within the statutory time limit and was suspected of violating laws and regulations in information disclosure. The China Securities Regulatory Commission decided to file a case against the company.